Literature DB >> 12166519

Chymotrypsin and neuraminidase treatment inhibits host cell invasion by Babesia divergens (Phylum Apicomplexa).

A Zintl1, C Westbrook, H E Skerrett, J S Gray, G Mulcahy.   

Abstract

The process of host cell invasion by Babesia divergens is poorly understood and improved knowledge of the mechanism involved could lead to development of measures effective in disease prevention. The investigate parasite ligands on the erythrocyte surface, B. divergens cultures in bovine erythrocytes were transferred into enzyme-treated bovine, human, ovine and equine erythrocytes. Parasite invasion of bovine erythrocytes was not affected by trypsin treatment while treatment with alpha-chymotrypsin led to a reduction in parasite growth of 20-40%. Treatment of bovine and non-bovine erythrocytes with neuraminidase decreased their susceptibility to invasion by up to 97% implicating sialic acid as an important erythrocyte ligand for babesia, but the addition of either bovine or human N-acetylneuraminyl-lactose to B. divergens cultures in bovine erythrocytes had no inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12166519     DOI: 10.1017/s0031182002001798

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  3 in total

1.  Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell.

Authors:  Cheryl-Ann Lobo
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Babesia and its hosts: adaptation to long-lasting interactions as a way to achieve efficient transmission.

Authors:  Alain Chauvin; Emmanuelle Moreau; Sarah Bonnet; Olivier Plantard; Laurence Malandrin
Journal:  Vet Res       Date:  2009-04-21       Impact factor: 3.683

3.  Individual heterogeneity in erythrocyte susceptibility to Babesia divergens is a critical factor for the outcome of experimental spleen-intact sheep infections.

Authors:  Laurence Malandrin; Maggy Jouglin; Emmanuelle Moreau; Alain Chauvin
Journal:  Vet Res       Date:  2009-02-27       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.